1.
Rev. neurol. (Ed. impr.)
; 43(5): 316-318, 1 sept., 2006. tab
Article
in Es
| IBECS
| ID: ibc-049441
ABSTRACT
No disponible
No disponible
Subject(s)
Humans , Gambling , Parkinson Disease/drug therapy , Antiparkinson Agents/adverse effects , Dopamine Agonists/adverse effects , Disruptive, Impulse Control, and Conduct Disorders/chemically induced , Antiparkinson Agents/administration & dosage , Dopamine Agonists/administration & dosage , Risk Factors
2.
Rev Neurol
; 43(5): 316-8, 2006.
Article
in Spanish
| MEDLINE
| ID: mdl-16941434